Neuroimaging in dementia

Neurologic Clinics

Volumn 18, Issue 4, 2000, Pages 885-901

  Jagust, William J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; BRAIN METABOLISM; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; HUMAN; IMAGE ANALYSIS; MULTIINFARCT DEMENTIA; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WHITE MATTER;

EID: 0034518258     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(05)70231-0     Document Type: Article

References (120)

1. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease
2. White matter lesions and disequilibrium in older people
3. Clinical correlates of high signal lesions on magnetic resonance imaging in Alzheimer's disease
4. Computed tomography in the elderly: Changes over time in a normal population
5. Brain blood flow in the dementias: SPECT with histopathologic correlation in 54 patients
6. Neuropsychological correlates of white matter lesions in healthy elderly subjects
7. Neuropathological staging of Alzheimer-related changes
8. Brain MR: Pathologic correlation with gross and histopathology: 1. Lacunar infarction and Virchow-Robin spaces
9. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The rotterdam study
10. Evaluation of dementia: A systematic study of the usefulness of the American Academy of Neurology's practice parameters
11. The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: A population-based study
12. Tracking neuronal fiber pathways in the living human brain
13. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease
14. Diagnosis and evaluation of dementia
15. Amygdala atrophy in Alzheimer's disease
16. Early marker for Alzheimer's disease: The atropic hippocampus
17. The radiologic prediction of Alzheimer disease: The atrophic hippocampal formation
18. Assessing utility of single photon emission computed tomography (SPECT) scan in Alzheimer disease: Correlation with cognitive severity
19. Imaging of the aging brain: Part I. Normal findings
20. Reduced temporal lobe blood flow in Alzheimer's disease
21. Cognitive correlates of regional cerebral blood flow in Alzheimer's disease
22. Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease?
23. Preservation of normal cognitive functioning in elderly subjects with extensive white matter lesions of long duration
24. Alzheimer's disease: Focal cortical changes shown by positron emission tomography
25. Cortical abnormalities in Alzheimer's disease
26. Visualization and quantification of rates of atrophy in Alzheimer's disease
27. Presymptomatic hippocampal atrophy in Alzheimer's disease: A longitudinal MRI study
28. Regional cerebral oxygen supply and utilization in dementia: A clinical and physiological study with oxygen- 15 and positron tomography
29. Regional cerebral metabolic alterations in dementia of the Alzheimer type: Positron emission tomography with [18F]fluorodeoxyglucose
30. Functional imaging, the frontal lobes, and dementia
31. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease
32. Clinical-neuropathological correlations in Alzheimer's disease and related dementia
33. Leukoencephalopathy in normal and pathologic aging: 1. CT of brain lucencies
34. Hippocampal atrophy in normal aging: An association with recent memory
35. Diffuse white matter disease in the geriatric population
36. Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type
37. Comparison of postmortem magnetic resonance imaging and neuropathologic findings in the cerebral white matter
38. Periventricular white matter changes and dementia: Clinical, neuropsychological, radiological and pathological correlation
39. Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease
40. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease
41. The scintigraphic appearance of Alzheimer's disease: A prospective study using technetium-99m-HMPAO SPECT
42. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease
43. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease
44. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease
45. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease
46. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
47. The diagnosis of dementia with single photon emission computed tomography
48. Functional imaging predicts cognitive decline in Alzheimer's disease
49. Brain perfusion imaging predicts survival in Alzheimer's disease
50. Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia
51. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: The use of NINCDS-ADRDA and DSM-III-R Criteria, SPECT, x-ray CT, and ApoE 4 in medial temporal lobe dementias
52. The diagnosis of Alzheimer's disease: A question of image?
53. Comparison of magnetic resonance and roentgen ray computed tomography in dementia
54. Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease
55. Preclinical prediction of Alzheimer's disease using SPECT
56. Cerebral perfusion imaging in Alzheimer's disease: Use of single photon emission computed tomography and iofetamine hydrochloride I 123
57. Leuko-araiosis on magnetic resonance imaging and speed of mental processing
58. Volumes of the entorhinal and perirhinal cortices in Alzheimer's disease
59. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia
60. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease
61. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease
62. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease
63. Subcortical arteriosclerotic encephalopathy (Binswanger's disease): Computed tomographic, nuclear magnetic resonance, and clinical correlations
64. Bladder function in elderly men with subclinical brain magnetic resonance imaging lesions
65. N-Acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: A preliminary proton nuclear magnetic resonance study
66. In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM
67. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease
68. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease
69. Brain N-acetyl-L-aspartic acid in Alzheimer's disease: A proton magnetic resonance spectroscopy study
70. Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study
71. MRI of the hippocampus in Alzheimer's disease: Sensitivity, specificity, and analysis of the incorrectly classified subjects
72. Diagnostic tests in the evaluation of dementia: A prospective study of 200 elderly outpatients
73. Association between medial temporal lobe atrophy on CT and parietotemporal uptake decrease on SPECT in Alzheimer's disease
74. Clinicopathologic correlations of cranial magnetic resonance imaging of periventricular white matter
75. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging
76. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: The Cardiovascular Health Study
77. Subcortical arteriosclerotic encephalopathy: CT spectrum and pathologic correlation
78. Rate of ventricular enlargement in dementia of the Alzheimer type correlates with rate of neuropsychological deterioration
79. Brain white-matter changes in the elderly prone to falling
80. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease
81. White matter lucencies on computed tomography, subacute arteriosclerotic encephalopathy (Binswanger's disease) and blood pressure
82. High resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: Comparison with fluorine-18-FDG PET
83. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging
84. Frontal lobe degeneration: Clinical, neuropsychological, and SPECT characteristics
85. Alzheimer disease: Depiction of increased cerebral myo-inositol with proton MR spectroscopy
86. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET
87. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
88. Periventricular venous collagenosis: Association with leukoaraiosis
89. Pathologic correlates of increased signals of the centrum ovale on magnetic resonance imaging
90. N-Acetyl-L-aspartic acid content of human neural tumours and bovine peripheral nervous tissues
91. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
92. Dementia of frontal lobe type
93. Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease
94. Mild cognitive impairment: Clinical characterization and outcome
95. Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease
96. Behind the scenes of functional brain imaging: A historical and physiological perspective
97. Neuropsychological test findings in subjects with leukoaraiosis
98. SPECT in dementia: Clinical and pathological correlation
99. Memory and regional cerebral blood flow in mildly symptomatic Alzheimer's disease
100. Preclinical evidence of Alzheimer's disease in persons homozygous for the e 4 allele for apolipoprotein E
101. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease
102. Differential diagnosis of Alzheimer's disease with PET
103. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging
104. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease: Evidence for heterogeneity
105. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal aging: Diagnostic value and neuropsychological correlates
106. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease: A proton MR spectroscopic imaging and MRI study
107. Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease
108. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer's disease
109. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease
110. Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease
111. Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis)
112. Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leukoaraiosis)
113. Foci of MRI signal (pseudo lesions) anterior to the frontal horns: Histologic correlations of a normal finding
114. 99mTc-HMPAO SPECT in the investigation of dementia?
115. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro
116. White matter abnormality in cerebral atrophy: Clinicoradiological correlations
117. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly: A morphometric correlation with arteriolosclerosis and dilated perivascular spaces
118. Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease
119. White matter signal changes in healthy elderly persons correlate with attention and speed of mental processing
120. Periventricular hyperintensity as seen by magnetic resonance: Prevalence and significance